Impact of platelet reactivity on individual thrombin generation in type 3 and 2 von willebrand disease: results from a small prospective study

被引：0
|
作者：
Szanto, T. [1 ,2 ]
Jokela, V. H. [1 ,2 ,3 ]
Jouppila, A. [4 ]
Lassila, R. [1 ,2 ,3 ]
机构：
[1] Univ Helsinki, Cent Hosp, Coagulat Disorders Unit, Dept Hematol,HUSLAB Lab Serv, Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Coagulat Disorders Unit, Dept Clin Chem,HUSLAB Lab Serv, Helsinki, Finland
[3] Univ Helsinki, Fac Med, Helsinki, Finland
[4] Univ Helsinki, Cent Hosp, Res Inst, Helsinki, Finland
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2016年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
VWF19
引用
收藏
页码：150 / 150
页数：1
相关论文
共 50 条
  • [31] Management of von Willebrand disease with a factor VIII-poor von Willebrand factor concentrate: Results from a prospective observational post-marketing study
    Goudemand, Jenny
    Bridey, Francoise
    Claeyssens, Segolene
    Itzhar-Baikian, Nathalie
    Harroche, Annie
    Desprez, Dominique
    Negrier, Claude
    Chamouni, Pierre
    Chambost, Herve
    Henriet, Celine
    Susen, Sophie
    Borel-Derlon, Annie
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (08) : 1922 - 1933
  • [32] Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis -: Results from a multicenter study in 47 patients
    Srámek, A
    Bucciarelli, P
    Federici, AB
    Mannucci, PM
    De Rosa, V
    Castaman, G
    Morfini, M
    Mazzucconi, MG
    Rocino, A
    Schiavoni, M
    Scaraggi, FA
    Reiber, JHC
    Rosendaal, FR
    CIRCULATION, 2004, 109 (06) : 740 - 744
  • [33] Frequency of Platelet type versus Type 2B von Willebrand Disease An international registry-based study
    Hamilton, Alexander
    Ozelo, Margareth
    Leggo, Jayne
    Notley, Colleen
    Brown, Hannah
    Pablo Frontroth, Juan
    Angelillo-Scherrer, Anne
    Baghaei, Fariba
    Enayat, Said M.
    Favaloros, Emmanuel
    Lillicrap, David
    Othman, Maha
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (03) : 501 - 508
  • [34] Results of a screening for von Willebrand disease type 2N patients with suspected haemophilia A or van Willebrand disease type 1
    Schneppenheim, R
    Budde, U
    Krey, S
    Drewke, E
    Bergmann, F
    Lechler, E
    Oldenburg, J
    Schwaab, R
    THROMBOSIS AND HAEMOSTASIS, 1996, 76 (04) : 598 - 602
  • [35] Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children
    Pablo Frontroth, Juan
    Hepner, Mirta
    Sciuccati, Gabriela
    Feliu Torres, Aurora
    Pieroni, Graciela
    Bonduel, Mariana
    THROMBOSIS AND HAEMOSTASIS, 2010, 104 (06) : 1158 - 1165
  • [36] Gene Sequencing Aids in Differentiation of von Willebrand Disease Type 2B from Platelet-Type vWD
    Desai, Diana Shirish
    Lyon, Elaine
    Rodgers, George
    Jama, Mohamed
    Wallentine, Steven
    Smock, Kristi
    FASEB JOURNAL, 2013, 27
  • [37] Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study
    Krahforst, Alexander
    Yadegari, Hamideh
    Pavlova, Anna
    Pezeshkpoor, Behnaz
    Mueller, Jens
    Poetzsch, Bernd
    Scholz, Ute
    Richter, Heinrich
    Trobisch, Heiner
    Liebscher, Karin
    Olivieri, Martin
    Trautmann-Grill, Karolin
    Knoefler, Ralf
    Halimeh, Susan
    Oldenburg, Johannes
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (11) : 3010 - 3034
  • [38] Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality
    Castaman, Giancarlo
    Federici, Augusto B.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2016, 42 (05): : 478 - 482
  • [39] Platelet clump visible to the naked eye in type 2B von Willebrand disease
    Al-Samkari, Hanny
    BLOOD, 2021, 138 (25) : 2742 - 2742
  • [40] Von Willebrand disease type 2A with aberrant structure of individual oligomers is caused by mutations clustering in the von Willebrand factor D3 domain.
    Schneppenheim, R
    Obser, T
    Schneppenheim, S
    Mainusch, K
    Angerhaus, D
    Budde, U
    BLOOD, 2000, 96 (11) : 566A - +
12345